Page 15 - Program Phase News Today

Late-breaker oral presentation by Professor Steve Vucic, University of Sydney Medical School and Northcott Chair of NeurologyCNM-Au8®demonstrated...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Sri Lankan policymakers prepared initiatives to improve resilience to climate risks, but they are going unimplemented, Jeevethan Selvachandran writes.

The project will support weather forecasting, warning, and flood resilience in the Kelani river basin The Government of Sri Lanka and the World Bank signed a $92 million financing agreement for the Climate Resilience Multi-Phased Program Phase I Project. This project is expected to benefit around 11.2 million people across the country by modernizing the weather,...

U.S. Initial Jobless Claims Edge Up But Hold Near Pandemic Low Jul 08 2021, 7:35 PM July 08 2021, 6:07 PM July 08 2021, 7:35 PM (Bloomberg) -- Applications for U.S. state unemployment insurance edged up last week, though remained near a pandemic low, as the labor market grinds its way toward a full recovery. (Bloomberg) -- Applications for U.S. state unemployment insurance edged up last week, though remained near a pandemic low, as the labor market grinds its way toward a full recovery. Initial...

Published June 10, 2021, 8:08 PM Hoping to spark the interest of applicant-Overseas Filipino Workers (OFWs) to start their own ventures, the Department of Science and Technology (DOST) conducted a series of pitching sessions showcasing its locally-developed technologies. ‘TeknoLokal para Makabagong Bayani’ aims to encourage OFWs to adopt DOST-developed technologies which will be funded under the Innovations for Filipinos Working Distantly from the Philippines (iFWD PH) Program. (Photo from ...

In Vitro Studies Show Ensovibep (MP0420) Maintains Full Potency Against the Known Mutations of SARS-CoV-2, Including Those Present in Variants First Identified in Brazil, California, India, and New

Share: In Vitro Studies Show Ensovibep (MP0420) Maintains Full Potency Against the Known Mutations of SARS-CoV-2, Including Those Present in Variants First Identified in Brazil, California, India, and New York, in Addition to the Previously Reported Varia Ongoing Phase 2 Pilot Study of Ensovibep in Ambulatory Patients Now Expanding Into Second Cohort Two Global Phase 2 and 3 Clinical Studies of Ensovibep on Track for Initiation This Month ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / May 6, 2021...

Share: ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / May 4, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced today its interim management statement for the period ending March 31, 2021. "Molecular Partners continues to grow and expand the reach of our DARPin® therapeutics platform, with the COVID-19 pandemic forming a meaningful change agent for us," said Patrick Amstutz, Ph.D...

(1) ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / May 4, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced today its interim management statement for the period ending March 31, 2021. "Molecular Partners continues to grow and expand the reach of our DARPin® therapeutics platform, with the COVID-19 pandemic forming a meaningful change agent for us," said Patrick Amstutz, Ph.D., ...